The store will not work correctly when cookies are disabled.
US8618286, 7
ID: ALA3675235
PubChem CID: 44599937
Max Phase: Preclinical
Molecular Formula: C17H22N4OS
Molecular Weight: 330.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCNCCN1CCOc2cc(/N=C(\N)c3cccs3)ccc21
Standard InChI: InChI=1S/C17H22N4OS/c1-2-19-7-8-21-9-10-22-15-12-13(5-6-14(15)21)20-17(18)16-4-3-11-23-16/h3-6,11-12,19H,2,7-10H2,1H3,(H2,18,20)
Standard InChI Key: SVSDOBDCHUJTMR-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
7.5395 -1.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4990 -0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8963 -3.7531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8941 -5.2539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8539 -5.8521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1923 -6.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3302 -7.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7974 -7.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5474 -6.5007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5437 -5.3860 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 6 1 0
15 10 1 0
12 16 1 0
16 17 2 0
17 18 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.46 | Molecular Weight (Monoisotopic): 330.1514 | AlogP: 2.59 | #Rotatable Bonds: 6 |
Polar Surface Area: 62.88 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.70 | CX LogP: 2.63 | CX LogD: -0.74 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.49 | Np Likeness Score: -1.90 |
References
1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, |